BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 22760778)

  • 1. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype.
    Basha BM; Bryant SC; Rech KL; Feldman AL; Vrana JA; Shi M; Reed KA; King RL
    Am J Surg Pathol; 2019 Sep; 43(9):1282-1290. PubMed ID: 31283630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.
    Zhan HQ; Li XQ; Zhu XZ; Lu HF; Zhou XY; Chen Y
    J Clin Pathol; 2011 Apr; 64(4):319-24. PubMed ID: 21330314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
    Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
    J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
    Abukhiran I; Syrbu SI; Holman CJ
    Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
    Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
    Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
    Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
    Jain S; Goswami A; Lone MR; Ramteke P; Gogia A; Aggarwal M; Viswanathan GK; Kakkar D; Mandal T; Sharma A; Sahoo R; Baldia A; Sharma MC; Bakhshi S; Pramanik R; Dhawan R; Kumar L; Mallick S
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):172-180. PubMed ID: 36806188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.
    Muto H; Sakata-Yanagimoto M; Nagae G; Shiozawa Y; Miyake Y; Yoshida K; Enami T; Kamada Y; Kato T; Uchida K; Nanmoku T; Obara N; Suzukawa K; Sanada M; Nakamura N; Aburatani H; Ogawa S; Chiba S
    Blood Cancer J; 2014 Dec; 4(12):e264. PubMed ID: 25501021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.